Click here to see the full list of Cantor's publications via PubMed.

Rothmeier A, Marchese P, Langer F Kamikubo T Scharrner F, Cantor JM, Ginsberg MH, Ruggeri Z, and Ruf W. Tissue factor protherombotic activity is regulated by integrin-arf6 trafficking.  Arteriosclerosis, Thrombosis, and Vascular Biology.  2017, In press.

Lagarrigue F, Gertler FB, Ginsberg MH, and Cantor JM.  Loss of T cell RIAM Disrupts Immunological Synapses and Prevents Immune-mediated Diabetes.  J Immunol., 2017, May 1; 198(9):2410-3415; PMID: 28348273.

Bajaj J, Konuma T,  Lytle NK, Kwon HY, Rizzieri D, Chuah C, Oehler VG, Ablack J, Cantor  JM, Van der Horst EH, Ginsberg MH and Reya T. CD98-mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia.  Cancer Cell.  2016 Nov 14;30(5):792-805; PMID: 27908736.

Liao, Z and Cantor JM. Endothelial Cells Require CD98 for Efficient Angiogenesis. Atherosclerosis, Thrombosis, and Vascular Biology.  2016 Nov;36(11):2163-2166; PMID: 27687603.

Abplanalp WT, Conklin DJ, Cantor JM, Ginsberg MH, Bhatnagar A, and O’Toole TE. Enhanced integrin a4β1-mediated adhesion contributes to a mobilization defect of endothelial progenitor cells in diabetes. Diabetes. 2016 Aug. 5;  PMID: 27495221.

Cantor JM. Homing Improvement: Boosting T cell Trafficking for Cancer Immunotherapy. In Donnadieu E (Ed), Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy, Springer Science and Business Media, 2016, 9:127-162.

Ablack JN, Metz PJ, Chang JT, Cantor JM, and Ginsberg MH. Ubiquitylation of CD98 limits cell proliferation and clonal expansion. J Cell Sci 2015 128: 4273-4278; PMID: 26493331.

Cantor JM, Rose DM, Slepak M, and Ginsberg MH. Fine-Tuning Tumor Immunity With Integrin Trans-regulation. Cancer Immunol Res. 2015 Jan 19;  PMID: 25600437.

Hayes GM, Chinn L, Cantor JM, Cairns B, Levashova Z, Tran H, Velilla T, Duey D, Lippincott J, Zachwieja J, Ginsberg MH, Van der Horst HE. Anti-tumor activity of an anti-CD98 antibody. Int J Cancer. 2014 Dec 29;  PMID: 25556716.

Liao Z, Kato H, Pandey M, Cantor JM, Ablooglu A.J, and Ginsberg MH, Shattil SJ. Interaction of kindlin-2 with integrin β3 promotes outside-in signaling responses by the αVβ3 vitronectin receptor. Blood. 2015 Jan 13;  PMID: 25587038.

Cantor JM. CD98 is a potential target for ablating B cell clonal expansion and autoantibody in multiple sclerosis. J Neuroimmunol. 2014 Sep 15;274(1-2):230-3;  PMID: 25002078.

Cantor JM, Ginsberg MH. CD98 at the crossroads of adaptive immunity and cancer. J Cell Sci. 2012 Mar 15;125(Pt 6):1373-82.

Cantor JM, Slepak M, Ege N, Chang JT, Ginsberg MH. Loss of T cell CD98 H chain specifically ablates T cell clonal expansion and protects from autoimmunity. J Immunol. 2011 Jul 15;187(2):851-60.

Cantor J, Browne CD, Ruppert R, Féral CC, Fässler R, Rickert RC, Ginsberg MH. CD98hc facilitates B cell proliferation and adaptive humoral immunity. Nat Immunol. 2009 Apr;10(4):412-9.

Cantor J, Ginsberg MH, Rose DM. Integrin-associated proteins as potential therapeutic targets. Immunol Rev. 2008 Jun;223:236-51.

Cantor J, Haskins K. Recruitment and activation of macrophages by pathogenic CD4 T cells in type 1 diabetes: evidence for involvement of CCR8 and CCL1. J Immunol. 2007 Nov 1;179(9):5760-7.

Cantor J, Haskins K. Interactions of macrophages and T cells in autoimmune diabetes. Drug Discovery Today: Disease Mechanisms. 2006 October 31; 3(3):381-385.

Cantor J, Haskins K. Effector function of diabetogenic CD4 Th1 T cell clones: a central role for TNF-alpha. J Immunol. 2005 Dec 1;175(11):7738-45.